What is the most common cause of aplastic anemia in adults: immune‑mediated damage to bone‑marrow stem cells, inherited bone‑marrow failure syndromes, chronic high‑altitude exposure, or excessive vitamin B12 intake?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Common Cause of Aplastic Anemia in Adults

The most common cause of aplastic anemia in adults is immune-mediated destruction of hematopoietic stem cells, where autoreactive cytotoxic T lymphocytes attack and destroy bone marrow stem cells. 1, 2

Pathophysiology of Immune-Mediated Aplastic Anemia

The immune mechanism is well-established as the primary driver in acquired aplastic anemia:

  • Oligoclonally expanded cytotoxic T cells induce apoptosis of hematopoietic progenitors through direct cellular attack. 1
  • Activated dendritic cells promote Th1 polarization and activate CD8+ T cells, creating a destructive cytokine network involving IFN-gamma, TNF-alpha, and multiple interleukins that destroy stem/progenitor cells. 3
  • Regulatory T cells are significantly reduced in patients' peripheral blood, removing normal immune suppression mechanisms. 1
  • T-bet, a transcription factor binding to the interferon-gamma promoter region, is upregulated in aplastic anemia T cells. 1

Why the Other Options Are Incorrect

Inherited Abnormalities

  • Inherited bone marrow failure syndromes (Fanconi anemia, telomere disorders) are more common in pediatric cases and represent only a minority of adult aplastic anemia. 4
  • In adults, inherited predisposition should be assessed primarily in young adults or families with multiple cases of MDS, AML, or aplastic anemia, but this is not the typical presentation. 4
  • Loss-of-function mutations in telomerase complex genes may underlie disease development in only a minority of cases. 1

Chronic High-Altitude Exposure

  • This is not a recognized cause of aplastic anemia in any medical literature or guidelines. 4
  • High altitude causes physiologic erythrocytosis (increased red blood cells), the opposite of aplastic anemia's pancytopenia. [General Medicine Knowledge]

Excessive Vitamin B12 Intake

  • This is completely incorrect - vitamin B12 deficiency (not excess) causes megaloblastic anemia, not aplastic anemia. 4
  • Laboratory evaluation for aplastic anemia specifically includes checking B12 and folate levels to exclude these nutritional deficiencies as alternative diagnoses. 4
  • Excessive B12 intake has no established association with bone marrow failure. [General Medicine Knowledge]

Clinical Implications

Most acquired aplastic anemia cases are classified as idiopathic (no identifiable trigger), though environmental exposures may trigger the aberrant immune response in some patients:

  • Drug exposures (chemotherapy, particularly alkylating agents and purine analogues) can trigger secondary aplastic anemia. 4
  • Benzene and its derivatives from occupational exposure are recognized triggers. 4
  • Viral infections may serve as triggers in some cases. 2
  • Despite these potential triggers, the underlying mechanism remains immune-mediated destruction. 2

Treatment Rationale Based on Etiology

The immune-mediated pathophysiology directly informs treatment:

  • Immunosuppressive therapy (antithymocyte globulin and ciclosporin) is effective because it targets the aberrant immune response. 1, 2
  • Allogeneic hematopoietic stem cell transplantation is preferred for children and young adults with severe aplastic anemia. 1, 5
  • High-dose cyclophosphamide provides an alternative immunosuppressive approach. 2

References

Research

Aplastic anemia.

Current opinion in hematology, 2008

Research

Aplastic anaemia.

Lancet (London, England), 2005

Research

Abnormal immunity and stem/progenitor cells in acquired aplastic anemia.

Critical reviews in oncology/hematology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.